Alzamend Neuro (ALZN) Amortizatization of Intangibles (2021 - 2024)
Alzamend Neuro's (ALZN) quarterly Amortizatization of Intangibles came in at $9286.0 in Q3 2024, up 155.1% quarter-over-quarter from -$16853.0 in Q1 2022.
Analysis
Alzamend Neuro (ALZN) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends
Alzamend Neuro has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $9286.0 for Q3 2024.
- In Q3 2024, Amortizatization of Intangibles changed N/A year-over-year to $9286.0; the TTM figure through Apr 2025 stood at $9286.0 (changed N/A YoY), while the FY2025 annual figure was $9286.0, up 1200.56% from the prior year.
- Amortizatization of Intangibles came in at $9286.0 for Q3 2024 at Alzamend Neuro, up from -$16853.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $51821.0 in Q1 2021 to a low of -$16853.0 in Q1 2022.
- Average Amortizatization of Intangibles over 3 years is $16746.2, with a median of $17057.0 recorded in 2021.
- The largest YoY upside for Amortizatization of Intangibles was 132.52% in 2022 against a maximum downside of 132.52% in 2022.
- Over 3 years, Amortizatization of Intangibles stood at $24828.0 in 2021, then tumbled by 167.88% to -$16853.0 in 2022, then surged by 155.1% to $9286.0 in 2024.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $9286.0 in Q3 2024, -$16853.0 in Q1 2022, and $24828.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 678,000.00 |
| 10 | Alzamend Neuro | 5.54 Mn | 5.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2024 | 9,286.00 |
| Jan 31, 2022 | -16,853.00 |
| Oct 31, 2021 | 24,828.00 |
| Jul 31, 2021 | 4,795.00 |
| Apr 30, 2021 | 26,600.00 |
| Jan 31, 2021 | 51,821.00 |